Xiaowen Chen

Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Efficacy and Long-term Prognosis of Flumatinib in the Treatment of Chronic Myelocytic Leukemia

Efficacy and Long-term Prognosis of Flumatinib in the Treatment of Chronic Myelocytic Leukemia

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: September 28, 2025

N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.

N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.

Journal: Molecular and cellular biochemistry
Published: August 18, 2023

Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.

Journal: Frontiers in oncology
Published: August 24, 2022

Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19.

Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19.

Journal: Frontiers in oncology
Published: April 16, 2022

TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes.

TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes.

Journal: Frontiers in oncology
Published: February 19, 2022

Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.

Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.

Journal: Frontiers in immunology
Published: May 09, 2021

Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.

Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.

Journal: Leukemia research
Published: January 14, 2021

Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib.

Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib.

Journal: Cancer management and research
Published: March 10, 2020

miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.

miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.

Journal: Cell cycle (Georgetown, Tex.)
Published: June 20, 2019

Mechanisms underlying the increased chemosensitivity of bortezomib-resistant multiple myeloma by silencing nuclear transcription factor Snail1.

Mechanisms underlying the increased chemosensitivity of bortezomib-resistant multiple myeloma by silencing nuclear transcription factor Snail1.

Journal: Oncology reports
Published: May 02, 2018

The in vitro study of apoptosis in NB4 cell induced by citral.

The in vitro study of apoptosis in NB4 cell induced by citral.

Journal: Cytotechnology
Published: September 27, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026